Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01SNR
|
||||
Former ID |
DNC004467
|
||||
Drug Name |
Firocoxib
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [525574] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H20O5S
|
||||
Canonical SMILES |
CC1(C(=C(C(=O)O1)OCC2CC2)C3=CC=C(C=C3)S(=O)(=O)C)C
|
||||
InChI |
1S/C17H20O5S/c1-17(2)14(12-6-8-13(9-7-12)23(3,19)20)15(16(18)22-17)21-10-11-4-5-11/h6-9,11H,4-5,10H2,1-3H3/i1D3,2D3
|
||||
InChIKey |
FULAPETWGIGNMT-WFGJKAKNSA-N
|
||||
CAS Number |
CAS 189954-96-9
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [525574] | |
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
NF-kappa B signaling pathway | |||||
VEGF signaling pathway | |||||
TNF signaling pathway | |||||
Retrograde endocannabinoid signaling | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Oxytocin signaling pathway | |||||
Regulation of lipolysis in adipocytes | |||||
Leishmaniasis | |||||
Pathways in cancer | |||||
Chemical carcinogenesis | |||||
MicroRNAs in cancer | |||||
Small cell lung cancer | |||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.